HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vesa Cheng Selected Research

Critical Illness (Critically Ill)

12/2023Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study.
1/2023Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation.
1/2022Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
1/2022Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
1/2022Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study).
12/2021Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
10/2021Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO Study.
11/2019Pharmacokinetics of flucloxacillin during prolonged intermittent renal replacement therapy in a 76-year-old man.
2/2019Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients.
1/2019Pharmacokinetics of Benzylpenicillin (Penicillin G) during Prolonged Intermittent Renal Replacement Therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vesa Cheng Research Topics

Disease

11Critical Illness (Critically Ill)
12/2023 - 01/2018
5Body Weight (Weight, Body)
12/2023 - 12/2021
2Infections
12/2023 - 11/2019
1AIDS-Related Complex (ARC)
01/2024
1Sepsis (Septicemia)
11/2019
1Bacteremia
01/2019
1Endocarditis
01/2019
1Delirium
03/2018
1Wounds and Injuries (Trauma)
01/2018
1Osteomyelitis
01/2018

Drug/Important Bio-Agent (IBA)

4CreatinineIBA
01/2022 - 12/2021
1Meropenem (Merrem)FDA LinkGeneric
01/2024
1Fluconazole (Zonal)FDA LinkGeneric
12/2023
1VancomycinFDA LinkGeneric
01/2022
1Serum AlbuminIBA
01/2022
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
01/2022
1Ciprofloxacin (Cipro)FDA LinkGeneric
01/2022
1Cefepime (Maxipime)FDA LinkGeneric
12/2021
1TazobactamFDA LinkGeneric
10/2021
1PiperacillinFDA LinkGeneric
10/2021
1Floxacillin (Flucloxacillin)IBA
11/2019
1Methicillin (Metin)FDA Link
11/2019
1Penicillins (Penicillin)FDA Link
01/2019
1Penicillin G (Benzylpenicillin)FDA LinkGeneric
01/2019
1tazobactam drug combination ceftolozaneIBA
01/2018

Therapy/Procedure

8Extracorporeal Membrane Oxygenation
12/2023 - 02/2019
3Intermittent Renal Replacement Therapy
11/2019 - 01/2018
2Continuous Renal Replacement Therapy
01/2024 - 12/2023
2Therapeutics
11/2019 - 03/2018
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2022